The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth

This study investigated the efficacy and safety of providing medication for opioid use disorder (MOUD) and individualized telehealth in Kentucky, a state severely impacted simultaneously by the opioid epidemic and the COVID-19 pandemic.

Source: Journal of Substance Abuse Treatment - June 25, 2021 Category: Addiction Authors: Richard H. Cales, Shannon C. Cales, Jacob Shreffler, Martin R. Huecker Source Type: research